A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies ; volume:13 ; number:1 ; day:14 ; month:1 ; year:2024 ; pages:173-187 ; date:1.2024
Infectious diseases and therapy ; 13, Heft 1 (14.1.2024), 173-187, 1.2024
- Creator
-
Moullan, Norman
Asiago, Josephat
Stecco, Kathryn
Hadi, Salah
Albizem, Moetaz
Tieu, Holly
Hock, Björn
Fenwick, Craig
Lin, Kai
Lengsfeld, Thomas
Poffenbarger, Lauren
Liu, David
Trono, Didier
Pantaleo, Giuseppe
Venkayya, Rajeev
Bhuyan, Prakash
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40121-023-00908-9
- URN
-
urn:nbn:de:101:1-2024041012163173804269
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:59 AM CEST
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Moullan, Norman
- Asiago, Josephat
- Stecco, Kathryn
- Hadi, Salah
- Albizem, Moetaz
- Tieu, Holly
- Hock, Björn
- Fenwick, Craig
- Lin, Kai
- Lengsfeld, Thomas
- Poffenbarger, Lauren
- Liu, David
- Trono, Didier
- Pantaleo, Giuseppe
- Venkayya, Rajeev
- Bhuyan, Prakash
- SpringerLink (Online service)